Evidence map›Paper›PMID 42904597›Full record

ArticleMolecular oncology2026

A role for eIF5A in translational control of stress-inducible proteins in multiple myeloma cell lines.

Demi Both, Ingrid A M Derks, Raphaël Vanleyssem, Marine Leclercq, Najla El Hachem, Pierre Close, Eric Eldering, Marco Vincent Haselager

Abstract read
In one paragraph

Article in Molecular oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Demi BothDepartment of Experimental Immunology, Amsterdam UMC, University of Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0003-3850-9913
Ingrid A M DerksDepartment of Experimental Immunology, Amsterdam UMC, University of Amsterdam, The Netherlands.
Raphaël VanleyssemGIGA-Institute, Université de Liège, Liège, Belgium.
Marine LeclercqGIGA-Institute, Université de Liège, Liège, Belgium.
Najla El HachemGIGA-Institute, Université de Liège, Liège, Belgium.
Pierre CloseGIGA-Institute, Université de Liège, Liège, Belgium.
Eric ElderingDepartment of Experimental Immunology, Amsterdam UMC, University of Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0003-0561-6640
Marco Vincent HaselagerDepartment of Experimental Immunology, Amsterdam UMC, University of Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0002-1410-7285

Funding

van der Laan FoundationWEL-RI Advanced Grant
6 · The paper itself

Abstract

Impaired protein folding in the endoplasmic reticulum (ER) causes ER stress and activates the unfolded protein response (UPR), which can induce apoptosis during prolonged ER stress. ER stress is therapeutically targeted in plasma cell malignancies, such as multiple myeloma (MM), but these treatments remain noncurative, and UPR signaling in B-cell malignancies is incompletely understood. A targeted CRISPR-Cas9 screen in RPMI-8226 cells exposed to thapsigargin identified known ER stress regulators (XBP1, IRE1, and calreticulin) and the translation factor eIF5A (eukaryotic translation initiation factor 5A), whose role in ER stress remains unclear. Competition assays showed that eIF5A depletion is detrimental under basal conditions but confers a proliferation advantage during thapsigargin treatment. Inducible EIF5A knockouts confirmed reduced sensitivity specifically to thapsigargin, loss of eIF5A had no or sensitizing effects on cell death induced by other ER stress drugs. Polysome profiling revealed that not general translation, but the translation of specific mRNA transcripts coding for UPR components and apoptotic proteins was affected by eIF5A depletion. Correspondingly, EIF5A KO cells showed reduced thapsigargin-induced UPR activation. In conclusion, these findings indicate that loss of eIF5A alters the stress response in MM cells.

Indexed as

apoptosiseIF5AER stressmultiple myelomatranslationUPR

Identifiers

PMID42904597
PMCPMC13685402

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.